MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT06132256 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06132256
- Sponsor
- Syndax Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-11
- Primary completion
- 2026-09-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.